SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Cognition Therapeutics Reports Q3 Net Loss

CGTX

Story updates

11:08:07 AM UTC
SquawkNews
Cognition Therapeutics 3Q Loss/Shr 4c >CGTX
11:09:57 AM UTC
SquawkNews
Cognition Therapeutics Q3 2026 Net Loss Narrows 16% to $4.15 Million Cognition Therapeutics’ thi
11:20:58 AM UTC
SquawkNews
Cognition Therapeutics Q3 net loss narrows on higher grant income
11:21:32 AM UTC
SquawkNews
Cognition Therapeutics’ net loss narrowed year over year as higher grant income and lower general and administrative expenses more than offset increased research and development spending. The company reported no revenue.Financial Highlights² Reported as “Net loss and comprehensive loss”. ³ Reported…

Related stories